Annual Total Liabilities
$6.29 M
-$19.38 M-75.50%
31 December 2023
Summary:
AcelRx Pharmaceuticals annual total liabilities is currently $6.29 million, with the most recent change of -$19.38 million (-75.50%) on 31 December 2023. During the last 3 years, it has fallen by -$107.50 million (-94.47%).ACRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$6.29 M
+$1.34 M+26.97%
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly total liabilities is currently $6.29 million, with the most recent change of +$1.34 million (+26.97%) on 31 December 2023.ACRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -94.5% | -94.5% |
| 5 y5 years | -95.3% | -95.3% |
ACRX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -95.3% | -95.3% |
AcelRx Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $6.29 M(-75.5%) | $6.29 M(+27.0%) |
| Sept 2023 | - | $4.95 M(-32.2%) |
| June 2023 | - | $7.31 M(-39.4%) |
| Mar 2023 | - | $12.05 M(-53.1%) |
| Dec 2022 | $25.67 M(-77.4%) | $25.67 M(+23.6%) |
| Sept 2022 | - | $20.77 M(-9.7%) |
| June 2022 | - | $22.99 M(-79.1%) |
| Mar 2022 | - | $110.24 M(-3.1%) |
| Dec 2021 | $113.79 M(-6.8%) | $113.79 M(-1.3%) |
| Sept 2021 | - | $115.28 M(-0.3%) |
| June 2021 | - | $115.58 M(+0.8%) |
| Mar 2021 | - | $114.66 M(-6.1%) |
| Dec 2020 | $122.05 M(-8.1%) | $122.05 M(-1.6%) |
| Sept 2020 | - | $124.03 M(-2.7%) |
| June 2020 | - | $127.53 M(-3.8%) |
| Mar 2020 | - | $132.62 M(-0.1%) |
| Dec 2019 | $132.77 M(+14.2%) | $132.77 M(-0.4%) |
| Sept 2019 | - | $133.25 M(-0.2%) |
| June 2019 | - | $133.53 M(+10.1%) |
| Mar 2019 | - | $121.33 M(+4.3%) |
| Dec 2018 | $116.28 M(+3.8%) | $116.28 M(+0.6%) |
| Sept 2018 | - | $115.53 M(+1.7%) |
| June 2018 | - | $113.59 M(+0.8%) |
| Mar 2018 | - | $112.69 M(+0.6%) |
| Dec 2017 | $112.06 M(+6.4%) | $112.06 M(-0.9%) |
| Sept 2017 | - | $113.05 M(+2.9%) |
| June 2017 | - | $109.81 M(+1.6%) |
| Mar 2017 | - | $108.10 M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $105.33 M(+11.3%) | $105.33 M(+2.5%) |
| Sept 2016 | - | $102.73 M(+2.7%) |
| June 2016 | - | $100.07 M(+2.3%) |
| Mar 2016 | - | $97.78 M(+3.3%) |
| Dec 2015 | $94.67 M(+138.1%) | $94.67 M(+3.4%) |
| Sept 2015 | - | $91.59 M(+203.6%) |
| June 2015 | - | $30.17 M(-12.6%) |
| Mar 2015 | - | $34.51 M(-13.2%) |
| Dec 2014 | $39.76 M(+7.8%) | $39.76 M(+6.4%) |
| Sept 2014 | - | $37.37 M(-16.6%) |
| June 2014 | - | $44.83 M(+26.8%) |
| Mar 2014 | - | $35.35 M(-4.1%) |
| Dec 2013 | $36.87 M(+20.2%) | $36.87 M(+34.3%) |
| Sept 2013 | - | $27.46 M(-21.0%) |
| June 2013 | - | $34.76 M(+11.9%) |
| Mar 2013 | - | $31.06 M(+1.3%) |
| Dec 2012 | $30.67 M(+31.3%) | $30.67 M(+7.7%) |
| Sept 2012 | - | $28.48 M(-1.9%) |
| June 2012 | - | $29.02 M(+26.4%) |
| Mar 2012 | - | $22.96 M(-1.7%) |
| Dec 2011 | $23.37 M(-67.9%) | $23.37 M(+75.1%) |
| Sept 2011 | - | $13.35 M(+6.2%) |
| June 2011 | - | $12.57 M(+109.5%) |
| Mar 2011 | - | $6.00 M(-91.7%) |
| Dec 2010 | $72.72 M(+7.8%) | $72.72 M(+865.4%) |
| Sept 2010 | - | $7.53 M(-88.8%) |
| Dec 2009 | $67.48 M(+20.5%) | $67.48 M |
| Dec 2008 | $56.01 M | - |
FAQ
- What is AcelRx Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for AcelRx Pharmaceuticals?
What is AcelRx Pharmaceuticals annual total liabilities?
The current annual total liabilities of ACRX is $6.29 M
What is the all time high annual total liabilities for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual total liabilities is $132.77 M
What is AcelRx Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ACRX is $6.29 M
What is the all time high quarterly total liabilities for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly total liabilities is $133.53 M